EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Serum GDF-15 Levels in Pediatric ADHD: Associations with Symptom Severity and Stimulant Exposure

Selçuk Özkan iD, Fatmagül Can, Asiye Höbel

Neuropsychiatric Disease and Treatment · 2026-07 · Volume 22 · 1-9

DOI: 10.2147/ndt.s622224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychiatric Disease and Treatment, 2026-07. Verfasst von Selçuk Özkan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, Faculty of Medicine, Kütahya Health Sciences University, Kütahya, Türkiye. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

GDF-15attention-deficit/hyperactivity disorderinflammationmethylphenidate

Autor:innen und Institutionen

  • Department of Child and Adolescent Psychiatry, Faculty of Medicine, Kütahya Health Sciences University, Kütahya, Türkiye.
  • Department of Biochemistry, Kütahya Health Sciences University, Kütahya, Türkiye.

ORCID-Profile: Selçuk Özkan

Zitieren

APA

Özkan, S., Can, F., & Höbel, A. (2026). Serum GDF-15 Levels in Pediatric ADHD: Associations with Symptom Severity and Stimulant Exposure. Neuropsychiatric Disease and Treatment, Volume 22, 1-9. https://doi.org/10.2147/ndt.s622224

Vancouver

Özkan S, Can F, Höbel A. Serum GDF-15 Levels in Pediatric ADHD: Associations with Symptom Severity and Stimulant Exposure. Neuropsychiatric Disease and Treatment. 2026;Volume 22:1-9. doi:10.2147/ndt.s622224

BibTeX
@article{zkan2026,
  author = {Özkan, Selçuk and Can, Fatmagül and Höbel, Asiye},
  title = {Serum GDF-15 Levels in Pediatric ADHD: Associations with Symptom Severity and Stimulant Exposure},
  journal = {Neuropsychiatric Disease and Treatment},
  year = {2026},
  volume = {Volume 22},
  pages = {1--9},
  doi = {10.2147/ndt.s622224}
}
Kostenlos starten →